Next Article in Journal
3D Modeling of the Adsorption Rate of Pyridine on Activated Carbon Cloth in a Stirred Tank under Turbulent Conditions
Previous Article in Journal
Reaction Extraction of Levulinic Acid and Formic Acid from Cellulose Deep Hydrolyzate
 
 
Article

Hinokitiol Dysregulates Metabolism of Carcinoma Cell Lines and Induces Downregulation of HPV16E6 and E7 Oncogenes and p21 Upregulation in HPV Positive Cell Lines

1
Department of Oral Pathology, Faculty of Medicine, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, 20520 Turku, Finland
2
Department of Pathology, Turku University Hospital, 20520 Turku, Finland
3
Department of Obstetrics and Gynecology, Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland
4
Department of Obstetrics and Gynecology, Tampere University Hospital, 33520 Tampere, Finland
*
Author to whom correspondence should be addressed.
Processes 2022, 10(4), 736; https://doi.org/10.3390/pr10040736
Received: 16 February 2022 / Revised: 5 April 2022 / Accepted: 7 April 2022 / Published: 11 April 2022
Background: Hinokitiol (β-thujaplicin), isolated from the wood of Chamaecyparis taiwanensis, has a wide variety of biological properties including anti-inflammatory, anti-microbial, and anti-tumor effects. Therefore, hinokitiol has become a frequent additive in oral and other healthcare products. Objectives: Our goal was to determine the anti-tumor activity of hinokitiol on human papillomavirus (HPV) positive (n = 3) and negative (n = 2) cell lines derived from cervical or head and neck squamous cell carcinoma (HNSCC) and keratinocyte cell lines (n = 3) transformed spontaneously or with HPV16E6 and E7 oncogenes. Methods: The cell-lines were exposed to hinokitiol at different concentrations (0–200 µM) for 24 h. Cell metabolism, proliferation, and the cell cycle distribution were assessed by MTT- and 3H-thymidine incorporation and flow cytometry. Expressions of p21 and on HPV16E6 and E7 oncogenes were assessed by qPCR. Results: In all carcinoma cell lines, hinokitiol treatment declined the metabolic activity irrespective of the HPV status. This decline was statistically significant, however, only in HPV-positive cell lines CaSki and UD-SCC-2 when exposed to hinokitiol concentrations at 100 and 200 µM, respectively (p < 0.05). Immortalized cell lines, HMK and HPV-positive IHGK, were more sensitive as a similar metabolic effect was achieved at lower hinokitiol concentrations of 3.1, 6.25, and 50 µM, respectively. Hinokitiol blocked DNA synthesis of all carcinoma cell lines without evident association with HPV status. G1 cell cycle arrest and p21 upregulation was found in all cell lines after hinokitiol treatment at higher concentration. However, when the p21 results of all HPV-positive cells were pooled together, the increase in p21 expression was statistically significantly higher in HPV-positive than in HPV-negative cell lines (p = 0.03), but only at the highest hinokitiol concentration (200 µM). In HPV-positive cell lines hinokitiol declined the expression of HPV16E7 and E6 along the increase of p21 expression. The dose-dependent inverse correlation between p21 and E7 was statistically significant in SiHa cells (r = −0.975, p-value = 0.03) and borderline in UD-SCC-2 cells (r = −0.944, p-value = 0.06), in which p21 and E6 were also inversely correlated (r = −0.989). Conclusions: Our results indicate that hinokitiol might have potential in preventing the progress of immortalized cells toward malignancy and the growth of malignant lesions. Hinokitiol can also influence on the progression of HPV-associated lesions by downregulating the E6 and E7 expression. View Full-Text
Keywords: hinokitiol; human papillomavirus; carcinoma; head and neck; cervical cancer; cell lines; p21; G1-arrest; HPV16E6E7; HPVE6; HPVE7 hinokitiol; human papillomavirus; carcinoma; head and neck; cervical cancer; cell lines; p21; G1-arrest; HPV16E6E7; HPVE6; HPVE7
Show Figures

Figure 1

MDPI and ACS Style

Sääskilahti, E.; Syrjänen, S.; Loimaranta, V.; Louvanto, K. Hinokitiol Dysregulates Metabolism of Carcinoma Cell Lines and Induces Downregulation of HPV16E6 and E7 Oncogenes and p21 Upregulation in HPV Positive Cell Lines. Processes 2022, 10, 736. https://doi.org/10.3390/pr10040736

AMA Style

Sääskilahti E, Syrjänen S, Loimaranta V, Louvanto K. Hinokitiol Dysregulates Metabolism of Carcinoma Cell Lines and Induces Downregulation of HPV16E6 and E7 Oncogenes and p21 Upregulation in HPV Positive Cell Lines. Processes. 2022; 10(4):736. https://doi.org/10.3390/pr10040736

Chicago/Turabian Style

Sääskilahti, Erika, Stina Syrjänen, Vuokko Loimaranta, and Karolina Louvanto. 2022. "Hinokitiol Dysregulates Metabolism of Carcinoma Cell Lines and Induces Downregulation of HPV16E6 and E7 Oncogenes and p21 Upregulation in HPV Positive Cell Lines" Processes 10, no. 4: 736. https://doi.org/10.3390/pr10040736

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop